NEW YORK (GenomeWeb News) – OpGen said today that it is working with the Beijing Genomics Institute to expand their use of OpGen's optical mapping technology for de novo sequence finishing in human, plant, and animal genomes.
The company said it has already used its Optical Mapping Technology with BGI to complete a study based on human genome data to successfully close gaps in existing sequence folds.
The firm's Argus system and Maplt services deliver whole-genome genetic maps from single DNA molecules, and it provides whole-genome analysis for strain typing, comparative genomics, and sequence assembly of microbial genomes to the life sciences market
"Applying the complementary technologies, we can develop more representative reference genomes at much improved standard," BGI VP of R&D Xun Xu said in a statement.
"It will allow more accurate and specific genomics research for different groups of people. Furthermore, the potential in human metagenomics research by developing improved microbe assemblies will facilitate the application in human disease studies," Xu added.